However, although SMURF2 should be assumed to play an opposite role from that of USP15, no reports have yet directly addressed the implication and underlying mechanisms of SMURF2 on the GSC phenotypes and subsequent glioma pathogenesis both in vivo and in vitro. The gene discussed is SMURF2; the disease is central nervous system cancer.